Lisdexamfetamine Dimesylate Chewable Tablet Shortage: Current Availability and Manufacturer Updates

What’s in Shortage

The FDA has identified a current shortage of Lisdexamfetamine Dimesylate in chewable tablet form. This medication, which falls under the therapeutic category of Psychiatry, is used by patients for various psychiatric conditions. The shortage was initially posted on July 14, 2023, and the status was most recently updated on February 3, 2026.

Which Manufacturers Are Affected

Currently, two manufacturers are supplying the market, though availability may vary by location and dosage strength.

• Novadoz Pharmaceuticals LLC

  • Status: Available (Note: Limited supply from Manufacturers)
  • Presentations: 10 mg (NDC 72205-132-91), 20 mg (NDC 72205-133-91), 30 mg (NDC 72205-134-91), 40 mg (NDC 72205-135-91), 50 mg (NDC 72205-136-91), and 60 mg (NDC 72205-137-91).
  • Contact Info: (855) 668-2369; [email protected]

• Sun Pharmaceutical Industries, Inc.

  • Status: Available
  • Presentations: 10 mg (NDC 57664-083-88), 20 mg (NDC 57664-084-88), 30 mg (NDC 57664-085-88), 40 mg (NDC 57664-086-88), 50 mg (NDC 57664-087-88), and 60 mg (NDC 57664-088-88).
  • Contact Info: 800-818-4555

Why There’s a Shortage

The FDA source data does not provide a specific reason for the current supply limitations or the limited supply reported by manufacturers.

What Patients Should Do

If you are prescribed Lisdexamfetamine Dimesylate chewable tablets and are having difficulty filling your prescription, consider the following steps:

• Speak with your pharmacist: They can provide information on current stock levels or check if the medication is available at other nearby locations.
• Consult your healthcare provider: Discuss your treatment options and ask about potential alternatives if your specific dosage is unavailable.
• Contact the manufacturers: You may use the contact information listed above to inquire about the availability of specific lots or presentations.

Disclaimer: Patients should always consult with their healthcare provider or pharmacist regarding medical concerns or changes to their medication regimen.

Source

Attribution: FDA Drug Shortage Database